![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 38, 35567-35573, September 20, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
andFrom the Department of Biological Sciences, State University of New York, Buffalo, New York 14260
Received for publication, June 13, 2002, and in revised form, July 9, 2002
| |
ABSTRACT |
|---|
|
|
|---|
Expression of genes involved in tryptophan
metabolism in Bacillus subtilis is regulated by the TRAP
protein in response to changes in L-tryptophan levels. TRAP
binding to several RNA targets that contain between 9 and 11 (G/U)AG
repeats regulates transcription and/or translation of these genes. TRAP
consists of 11 identical subunits and is activated to bind RNA by
binding up to 11 molecules of tryptophan. To investigate the mechanism
by which tryptophan binding activates TRAP, we generated hetero-11-mers
containing different proportions of subunits from wild type (WT)
TRAP that bind tryptophan and from a mutant TRAP (Thr25 to
Ala) defective in tryptophan binding. Studies of these hetero-11-mers show that tryptophan-binding sites created from active subunits bind tryptophan with similar affinity to those in WT homo-11-mers, whereas sites containing the T25A substitution do not bind tryptophan. Hetero-11-mers with very few (one or two) bound tryptophans show only 10-fold lower affinity than WT TRAP for an RNA with 11 GAG repeats, whereas TRAP with no bound tryptophan shows no detectable binding to this RNA. We also demonstrate that tryptophan binding induces a conformational change in TRAP in the vicinity of the RNA-binding site, suggesting a possible mechanism for activation of RNA binding.
Tryptophan biosynthesis in Bacillus subtilis requires
the products of seven trp genes (1). Expression of these
genes, which are located in the trpEDCFBA and folate
operons, is negatively regulated by TRAP
(trp RNA-binding
attenuation protein) in response to changes in
the intracellular levels of L-tryptophan (2-4). TRAP
regulates both transcription of the trp operon and translation of its initial structural gene, trpE. In the
presence of excess tryptophan, TRAP binds to the 5' leader region of
the nascent trp mRNA, facilitating formation of a
transcription terminator, which halts transcription prior to the
structural genes. Under conditions of limiting tryptophan, TRAP does
not bind to the trp leader RNA, thus allowing it to form an
alternative antiterminator structure that permits transcription to
continue into the structural genes (2). TRAP also binds to the leader
region of nonterminated trp mRNAs that have extended
through the attenuator region, and this binding alters the RNA
structure so as to sequester the trpE Shine-Dalgarno
sequence and inhibit translation initiation of this gene (3-5).
Translation of trpG, which is located within the folate
operon, is also regulated by TRAP; in regulating expression of this
gene, TRAP competes directly with ribosomes for binding to the mRNA
(3, 6, 7). TRAP also regulates translation of yhaG (8) and
ycbK (9). The former gene is predicted to encode a
tryptophan transport protein (8), whereas the function of the latter
gene product is unknown.
TRAP is composed of 11 identical subunits arranged in a symmetric ring
(10, 11). The secondary structure mainly consists of 11 seven-stranded
antiparallel The observations that TRAP is composed of 11 identical subunits that
create 11 binding sites for L-tryptophan between adjacent subunits and that TRAP binds RNAs with up to 11 (G/U)AG repeats (with
restricted spacing between repeats) raise several issues with regard to
how this protein functions to regulate gene expression. TRAP must avoid
binding to RNAs with only several (G/U)AG repeats, and it must only
bind its various RNA targets at the appropriate level of intracellular
tryptophan. Little is known about how tryptophan binding activates TRAP
to bind RNA. The structure of TRAP in the absence of tryptophan is not
known; however, previous studies have shown that the apo-protein
remains an 11-mer (15). In particular, the relationship between the
number of bound tryptophan molecules and the number of RNA-binding
sites activated is not known. Because the binding of 11 molecules of
tryptophan to TRAP is positively cooperative (10, 16, 17), it has been
difficult to directly analyze the properties of TRAP 11-mers containing
defined subsaturating levels of bound tryptophan.
Recently we have developed a method to generate TRAP hetero-11-mers
composed of two different types of subunits, such as mutant and wild
type (WT).1 Our data show
that the mutant subunits can assemble randomly with WT subunits
yielding a total of 12 different species of 11-mers (the two
homo-11-mers and 10 different possible hetero-11-mers) (15). By varying
the ratio of the two types of subunits that are mixed, we can change
the abundance of each species within the mixture of renatured
hetero-11-mers. In this paper, we created TRAP hetero-11-mers composed
of subunits from WT TRAP and subunits from a mutant protein defective
in tryptophan binding. Residues from two adjacent subunits contribute
to the formation of each tryptophan-binding site on TRAP (10) (Fig.
1). Hence within the hetero-11-mers there
are two different types of tryptophan-binding sites. In one case the
binding site contains the altered residue from the mutant subunit. Our
data indicate that these sites do not bind tryptophan. The second type
of binding site is created from the juxtaposition of two fully
functional regions from the two adjacent active subunits, either two
wild type subunits or the unaltered portion of a mutant subunit
combined with that from a wild type subunit. Our results show that
these sites bind tryptophan with an affinity similar to that of those
in the wild type homo-11-mer.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS AND DISCUSSION
REFERENCES
-sheets, each formed from
-strands from two adjacent
subunits. 11 tryptophan-binding sites are formed between adjacent
subunits, and each tryptophan interacts with amino acid residues of
both subunits (see Fig. 1). When activated by 11 tryptophan molecules,
TRAP binds to RNAs containing multiple (up to 11) (G/U)AG triplet
repeats optimally separated by two or three nonconserved nucleotides
(10, 12, 13). The crystal structure of TRAP complexed with an RNA
containing 11 GAG repeats shows that the single-stranded RNA wraps
entirely around the outer perimeter of the protein ring forming
specific interactions between the bases of the RNA and the protein
(14).

View larger version (41K):
[in a new window]
Fig. 1.
Ribbon diagram of three adjacent TRAP
subunits bound to RNA. Each subunit is shown in a different color:
yellow, olive, and green. The
-strands are shown as arrows, and the bound
L-tryptophan molecules are shown as van der Waals'
spheres. The Thr25 side chain on each
subunit is shown in ball-and-stick models. Each
tryptophan-binding site is created from elements on two adjacent
subunits, and each subunit contributes to two tryptophan-binding sites.
The bound RNA is shown in ball-and-stick format. The native
TRAP protein contains 11 subunits arranged in a ring.
We also show that binding only one or two tryptophan molecules to
hetero-11-mers (those with only one or two active binding sites)
dramatically stabilizes the TRAP-RNA complex as compared with TRAP
11-mers with no bound tryptophan. The affinity of these TRAP
hetero-11-mers for RNA depends on both the number of tryptophan molecules bound and the number of (G/U)AG triplet repeats in the target
RNA, suggesting that nonliganded subunits within the hetero-11-mers contribute to the stability of complexes with RNA. Our studies also
indicate that tryptophan binding induces a conformational change in
only the subunits to which it is bound. Together, our results suggest
that binding one or two tryptophan molecules activates RNA-binding
sites associated with these tryptophan-binding sites and that this
activation plays a crucial role in nucleating the TRAP-RNA interaction.
Once this initial RNA-binding complex is formed, the remaining
RNA-binding sites on the protein can interact with the RNA even though
they have not been activated by bound tryptophan.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
RNA Synthesis and TRAP Purification--
Wild type and mutant
mtrB genes encoding TRAP were subcloned on
EcoRI/HindIII fragments following the T7 promoter
in pBlueScript (Stratagene) and were expressed in the Escherichia
coli strain BL21 as described previously (18). We followed a
previously published protocol to purify TRAP by immunoaffinity
chromatography (19). The concentration of each protein was determined
by UV absorbance (extinction coefficient of 1280 M
1 cm
1 at 280 nm) and confirmed
by BCA protein assay (Pierce) and SDS-PAGE. (GAGAU)n RNA, where
n indicates the number of tandem GAGAU repeats, was
transcribed in vitro using T7 RNA polymerase and labeled
with [
-32P]UTP (PerkinElmer Life Sciences) as
described previously (19).
Subunit Mixing-- Subunit mixing was performed as described previously by Li et al. (15). Various ratios of WT and mutant TRAP proteins (0.5-5.0 mg/ml) were denatured in 4 M guanidine hydrochloride (Angus, Niagara Falls, NY) at room temperature for 1 h. The mixtures were then dialyzed against 50 mM phosphate buffer (pH 8.0) overnight. The concentrations of renatured proteins were quantified by BCA protein assay (Pierce) and SDS-PAGE based on comparison with known TRAP standards.
Tryptophan and RNA Binding--
Tryptophan binding to TRAP was
measured at 37 °C by circular dichroism spectroscopy using a JASCO
model J-715 spectrapolarimeter. The spectra were recorded between 190 and 300 nm for 5 µM TRAP 11-mers in the presence of
various concentrations of tryptophan. At each tryptophan concentration,
the spectrum of free tryptophan was subtracted. The CD at 225 nm, which
shows the maximal difference between spectra of apo- and liganded TRAP,
was used to measure tryptophan binding. CD225 (
) of free
tryptophan increases linearly with concentration, whereas the net CD
signal (
) from bound tryptophan to TRAP saturates at high
concentrations of tryptophan. The values of 
were normalized to
give 
% by comparing to maximal CD signal change at saturation
and 
% were fit to following the Hill equation (10, 18, 21).
|
(Eq. 1) |
RNA binding to TRAP in the presence of 100 mM tryptophan was determined using a nitrocellulose filter binding assay at 37 °C (15, 20). The reactions were incubated at 37 °C for 1 h before filtering. For each assay, at least one set of reactions was performed in the absence of tryptophan, as a control. The data were analyzed using a nonlinear least squares fitting to single binding site equation (20) (Prizm, Graphpad Software Inc., San Diego, CA).
Fluorescence Labeling Assay--
200 ng of
5-iodoacetamidofluorescein (5-IAF; Molecular Probes) in 50 mM sodium phosphate (pH 7.5) was quickly mixed with 10 µg
of TRAP in a total of 100 µl. The reaction was stopped after 0.5-20
min by adding SDS-PAGE loading buffer containing 0.1 M
-mercaptoethanol. The samples were run on 15% SDS-PAGE to separate free dye from labeled proteins. Digital images of the gel were taken
using a 312-nm transilluminator and a Kodak DC290 digital camera.
Fluorescence intensities of bands were quantified using 1D Kodak
software, version 3.5. The number of 5-IAF molecules bound per TRAP
11-mer was determined by comparison with intensities of free
fluorophore at known concentrations. To adjust the loading errors, the
gels were subsequently stained with Coomassie Brilliant Blue to
determine the protein concentration.
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Constructing WT-T25A Heteromeric TRAP Mixtures--
We created
heteromeric TRAP 11-mers composed of various ratios of subunits derived
from wild type 11-mers and from mutant 11-mers that are inactive for
tryptophan binding, so as to mimic situations in which the wild type
TRAP protein has different numbers of bound tryptophan molecules. As
the source of inactive subunits, we used the mutant TRAP protein T25A
(Thr25 in the tryptophan-binding pocket changed to Ala).
This protein is defective in tryptophan binding and does not bind RNA
(18). Because the T25A protein contains all the residues shown to be involved in complex formation with RNA (14, 18), we assume that the
RNA-binding sites on this protein are structurally identical to those
in WT TRAP. The active subunits were from a mutant TRAP protein in
which Lys71 is replaced by Ala (K71A). The advantage of
using this protein is that because of the charge change (Lys to Ala) on
the surface of each subunit, K71A TRAP displays faster mobility on
native polyacrylamide gels than the T25A protein. This property allows us to distinguish hetero-11-mers with different subunit compositions using these gels (Fig. 2).
Lys71 is distant from the tryptophan and RNA-binding sites
on TRAP (10, 14), and K71A TRAP is fully active both in vivo
(18) and in vitro (15). Moreover, all hetero-11-mers
composed of WT and K71A subunits are fully active in tryptophan binding
and in RNA binding (15). For simplicity, we will refer to K71A subunits as WT in this paper.
|
To construct WT-T25A TRAP hetero-11-mers, we denatured WT and T25A TRAP 11-mers into unfolded monomers using guanidine hydrochloride, mixed the two types of subunits in various ratios, and regenerated 11-mers by dialysis in sodium phosphate buffer (15). All pools of heteromers have similar secondary structure as WT TRAP homo-11-mers, based on CD analysis, and all have assembled as 11-mers based on size exclusion chromatography (data not shown). When displayed on native polyacrylamide gels, these pools show a total of 12 different bands corresponding to the two homo-11-mers (WT and T25A) and 10 hetero-11-mers with different numbers of each type of subunit (10WT-1T25A, 9WT-2T25A, etc.) (Fig. 2). The distribution of heteromers on the gel is nearly identical to that predicted based on random association of mutant and WT monomers. Thus there is no evidence suggesting preferential association of either type of monomer. We previously observed similar random assembly of 11-mers when monomers from several other TRAP mutant proteins were mixed with WT subunits (15).
Tryptophan Binding of WT-T25A Heteromeric Mixtures--
Assembly
of WT and T25A subunits into hetero-11-mers creates two different types
of tryptophan-binding sites, those with Thr at position 25 (from the WT
subunits) and those with the Ala substitution at position 25 (from the
T25A subunits) (Fig. 1). To characterize the tryptophan binding
properties of WT-T25A heteromers, we developed an assay based on
changes in the CD spectrum of TRAP upon tryptophan binding (Fig.
3). The CD spectrum of WT TRAP in the
absence of tryptophan (apo-TRAP) is typical of a protein composed
predominately of
-sheet secondary structure, showing a negative peak
near 215 nm (Fig. 3A) (15, 20). In the presence of
tryptophan, a new positive peak appears near 228 nm. This spectral
change occurs for all TRAP proteins that we tested that bind tryptophan
but does not occur in the spectra of mutant TRAP proteins, such as T25A
(data not shown), which are defective in tryptophan binding. These
observations establish that this change is due to tryptophan binding to
TRAP. Examining the CD228 of WT TRAP as a function of
tryptophan concentration at 37 °C (Fig. 3B) yielded an
apparent S0.5 of 24 µM and a Hill
coefficient (n) of 1.2 (Table
I), both values are similar to those
derived previously from equilibrium dialysis of wild type TRAP
at 5 °C (S0.5 = 5-10
µM and n = 1.5-2.0) (10, 17, 18),
although the S0.5 value is somewhat higher, and
the Hill coefficient is slightly lower. These differences may be due to
the different temperature used in the current studies.
|
|
We next examined the tryptophan binding properties of heteromeric mixtures composed of various ratios of WT and T25A subunits (Fig. 3B and Table I). We measured the number of tryptophan molecules/TRAP protein bound in these pools. To do so, we compared the saturation level of tryptophan binding to each pool to that of WT TRAP, which is known to bind 11 tryptophan molecules/11-mer (10). Because the heteromer pools contain mixtures of hetero-11-mers with different ratios of WT and mutant subunits, the values we measured represent weighted averages (and thus cannot be directly ascribed to any one member of the pool). We found that the saturation of tryptophan binding to the heteromeric mixtures depends directly on the percentage of WT subunits used in the pool (Table I). These findings were confirmed by equilibrium dialysis (data not shown). The simplest interpretation of these results is that assembly of hetero-11-mers composed of WT and T25A mutant subunits is random and that tryptophan-binding sites containing Thr25 contributed from WT subunits retain their ability to bind tryptophan, whereas those with the alanine substitution at residue 25 do not bind tryptophan under these conditions. We refer to the former type of binding sites as active binding sites and the latter as inactive binding sites. Thus in the presence of excess tryptophan, the hetero-11-mers created with different ratios of WT and T25A subunits can be considered to represent randomly assembled TRAP 11-mers with various numbers of tryptophan molecules bound, depending on their subunit composition.
The observed affinity of the heteromeric pools for tryptophan (S0.5 total)) decreased from 24 µM for the WT homo-11-mer to 67 µM for the pool composed of 25% WT and 75% T25A (Table I). However, if we assume that only the active binding sites within the hetero-11-mers bind tryptophan (as indicated above) and normalize the observed affinities to the fraction of active binding sites in the mixtures, we find that the affinity of the active sites (S0.5 (WT)) does not change significantly within the hetero-11-mer pools (Table I). The Hill coefficient (n) decreases slightly from 1.2 to 0.89 as the percentage of WT subunit in the pool drops from 100 to 25%, suggesting that introduction of the mutant subunits interferes with the cooperativity of tryptophan binding.
The Hill coefficient of 1.2-2.0 for WT TRAP binding 11 tryptophan molecules as determined by equilibrium dialysis (10, 17, 18) or by CD measurements (Fig. 3) indicates a low degree of positive cooperativity. This is because the maximal possible value of n for fully cooperative binding in this system is 11, the total number of binding sites on the protein, and n equals 1.0 for noncooperative binding (21, 22). Our results are consistent with a model in which, following tryptophan binding to one or mores sites on the TRAP 11-mer, two types of unoccupied tryptophan-binding sites are generated: "empty" and "activated" sites. The simplest model for the generation of cooperativity is that tryptophan binding to the first site activates only the neighboring site(s) and increases their affinity for tryptophan. However, we cannot rule out a model in which tryptophan binding to one site on TRAP moderately increases the affinities of the remaining 10 unoccupied sites. The most significant implication of our findings is that there may be conditions in vitro or in vivo where wild type TRAP binds to less than its full complement of 11 tryptophan molecules.
RNA Binding of WT-T25A Heteromeric Mixtures-- We next addressed the question of how many bound tryptophans are required to activate the TRAP 11-mer for RNA binding? WT TRAP binds (GAGAU)11, an RNA with 11 tandem GAGAU repeats, with a Kd of 1.6 nM in the presence of excess tryptophan (Table II). However, neither WT TRAP in the absence of tryptophan nor T25A TRAP homo-11-mer in the presence or absence of tryptophan shows measurable binding to this RNA (at protein concentrations up to 5 µM). T25A TRAP has all the residues shown to be involved in RNA binding in the crystal structure of the TRAP RNA complex (14) as well as by biochemical studies (18). However, T25A TRAP is inactive because it does not bind tryptophan, which is necessary to activate TRAP for RNA binding. We measured the affinity of several pools of hetero-11-mers containing various ratios of WT to T25A subunits for the RNA (GAGAU)11, in the presence of excess tryptophan (Table II). The affinity of the hetero-11-mer pools for this RNA decreased from a Kd of 1.6 to 12 nM as the percentage of WT subunits in the mixture dropped from 100 to 5% (Table II). In every instance, RNA binding was tryptophan-dependent (data not shown). The presence of RNA did not alter the saturation level of tryptophan binding (data not shown), indicating that bound RNA does not influence the ability of binding sites containing the T25A substitution to bind tryptophan. We have also found that bound RNA does not alter the tryptophan binding properties of WT TRAP.2
|
Several lines of evidence suggest that hetero-11-mers of WT and T25A TRAP form similar complexes with RNA as does WT TRAP. The heteromers form complexes with (GAGAU)11 that migrate with similar mobility on native gels as that with WT TRAP (data not shown). In addition, near-UV CD spectroscopy studies (data not shown) indicate that the RNA bound to these hetero-11-mers undergoes similar conformational changes as occur upon complex formation with WT TRAP (20, 23).
Surprisingly, the hetero-11-mer pools containing only 5-10% WT subunits bound (GAGAU)11 RNA with Kd values of 12 and 6.5 nM, respectively, which are only 7.5- and 4-fold weaker than for WT TRAP, even though the hetero-11-mers in these pools were predicted to contain an average of only approximately one WT subunit. In contrast, we detect virtually no specific RNA binding to T25A homo-11-mers (Table II). One explanation for these findings could be that the observed RNA binding affinity is due to the presence of a fraction of WT homo-11-mers or hetero-11-mers with large numbers of WT subunits within our heteromer pools. The measured affinity (as Kd) for any pool is the weighted average of the dissociation constants for each of the TRAP hetero-11-mer species comprising the pool. Our results show that subunit mixing to generate these heteromers is based on random assortment (Fig. 2), and hence the composition of each pool is predicted by a binomial distribution (15). Hence WT homo-11-mers are predicted to represent less than 1:1014 of the population in the mixture with 5% WT subunits (WT11 = 0.0511 %) and less than 1.5% of the total 11-mers in this pool will have more than two WT subunits. Native gel analysis of these pools is consistent with these predictions because all the visible bands run just adjacent to the T25A homo-11-mer, i.e. there are no visible bands corresponding to hetero-11-mers with large numbers of WT subunits (data not shown). In the mixture with 5% WT subunits, if all hetero-11-mers containing three or more WT subunits bind (GAGAU)11 RNA with the same affinity as WT homo-11-mer (and the remaining heteromers do not contribute to the observed affinity), the predicted apparent Kd for the mixture would be 106 nM (1.6 nM/1.5%). This value is much higher than that observed (12 nM). Hence these data suggest that the binding of as few as one or two tryptophan molecules sufficiently activates a TRAP 11-mer so that its complex with RNA is significantly stabilized.
It is possible that the observed affinities of (GAGAU)11
RNA for the members of the hetero-11-mer pools containing 5 or 10% WT
subunits (Kd values of 12 and 6.5 nM)
are the results of only the tryptophan-bound subunits (WT and possibly
the adjacent T25A subunits) in the heteromers interacting with the RNA.
If this were the case, most of the T25A subunits in the heteromers would not contribute to the complex. However, several lines of evidence
argue against this hypothesis. We have previously shown that RNAs with
three or fewer GAG repeats bind to WT TRAP very weakly
(Kd
800 nM) (24). Therefore, it seems
unlikely that the high affinities that we observed for heteromers with low percentages of WT subunits are due solely to the interactions between the few WT subunits and a small number of GAG repeats. Thus our
results suggest that in these hetero-11-mers, many (or all) of the T25A
subunits contribute to the stability of the complex with RNA, even
though they have not bound tryptophan. To test this hypothesis, we
measured the affinity of these heteromeric TRAP pools for RNAs
containing 3-11 GAG repeats (Table II). For all of the heteromeric
pools, the affinity for RNA increased as the number of triplet repeats
increased. This effect is particularly evident for pools that contain
low (5-10%) fractions of WT subunits. Because the hetero-11-mers in
these low WT percentage pools contain an average of approximately one
WT subunit each, these results strongly suggest that RNA-binding sites
associated with defective tryptophan-binding sites contribute to the
complex with RNA in these hetero-11-mers. This conclusion is further
supported by nuclease protection studies that demonstrate that all 11 trinucleotide repeats are protected from digestion by the heteromeric
TRAP pools.3 In previous
studies, we also obtained several lines of evidence suggesting that
mutant subunits (15) or partially defective triplet repeats (24)
contribute to the stability of the TRAP-RNA complex when accompanied by
at least one WT subunit and one fully functional RNA triplet repeat.
Tryptophan Binding Induces a Conformational Change in TRAP-- The mechanism by which bound tryptophan activates TRAP to bind RNA is not known. Several studies have shown that the protein remains an 11-mer in the absence of bound tryptophan (15),4 and hence tryptophan binding does not activate TRAP by assembling the 11-mer. Furthermore, neither the bound tryptophan nor any of the amino acid residues that contact tryptophan directly interact with the RNA (14) (Fig. 1). Hence we have proposed that tryptophan binding induces a conformational change in TRAP that activates its RNA binding ability (10, 14, 18). Here we report the first direct evidence for this hypothesis.
RNA binds to activated TRAP by wrapping around the outside of the
protein ring. Each GAG repeat in the bound RNA interacts with residues
on two adjacent protein subunits including Lys37 and
Glu36 from one subunit and Phe32,
Lys56, and Arg58 from the adjacent subunit
(14). Asn20 lies in the RNA-binding region between residues
Lys37 and Arg58 but does not interact with the
RNA. Asn20 is also distant from the tryptophan-binding
sites and forms no direct contact with tryptophan. Virtually any other
amino acid can be substituted for Asn20 without affecting
TRAP function (18). In particular, TRAP with cysteine at position 20 (N20C) binds tryptophan and RNA similarly to WT TRAP (data not shown).
Because there are no other cysteine residues in TRAP (25), it is
possible to specifically fluorescently label position 20 of N20C TRAP
with 5-IAF, a thiol-reactive fluorophore. After incubation with 5-IAF,
N20C TRAP shows strong green fluorescence (Fig.
4), whereas there is virtually no
fluorescence from similarly treated WT TRAP (data not shown). We found
that the rate of labeling N20C TRAP is greatly reduced by the presence
of L-tryptophan but is not affected by
D-tryptophan (Fig. 4), suggesting that Cys20 is
more accessible to 5-IAF in apo-TRAP than in the TRAP-tryptophan complex. These findings support the hypothesis that bound tryptophan induces conformational changes in the vicinity of the RNA-binding sites
of TRAP.
|
There are two obvious interpretations of the observation that binding of just one tryptophan molecule to a TRAP 11-mer significantly activates TRAP to bind RNA. The first possibility is that the binding of one tryptophan molecule to these hetero-11-mers induces a conformational change in only the subunits to which it binds but that this dramatically stabilizes the TRAP-RNA complex as compared with an entirely unliganded 11-mer (either defective in tryptophan binding or WT TRAP in the absence of tryptophan). The second possibility is that binding of one tryptophan molecule to a TRAP 11-mer induces a conformational change in many or all of the 11 subunits. To distinguish between these two possibilities, we examined 5-IAF labeling of hetero-11-mers created from 10% WT and 90% N20C/T25A double mutant TRAP subunits. These hetero-11-mers contain, on average, one WT subunit, which is active in binding tryptophan but contains no Cys residues (and thus is not labeled by 5-IAF), and 10 N20C/T25A subunits, which can be labeled at Cys20 with 5IAF but contain the Thr25 to Ala substitution that eliminates tryptophan binding. If tryptophan binding to the WT subunits induces a conformational change over the entire hetero-11-mer, then the rate of labeling of this protein should be inhibited. However, we found that the rate of 5IAF labeling of both N20C/T25A mutant TRAP as well as the hetero-11-mer pool containing 10% WT and 90% N20C/T25A subunits was not reduced by added tryptophan (Fig. 4A). These data suggest that tryptophan binding does not induce conformational changes throughout the T25A subunits in these hetero-11-mers. These results thus favor the model in which tryptophan binding induces a conformational change only in the subunits to which it binds. Moreover, these findings suggest that the significant activation of RNA binding observed when only one or two tryptophan molecules are bound to TRAP is due to conformational changes in just a few subunits.
Implications-- Based on our previous studies using nucleoside analogs (24) as well as with TRAP hetero-11-mers containing WT subunits together with those from a mutant protein defective in RNA binding (15), we have proposed the following model for RNA binding to tryptophan-activated TRAP. Binding initiates between several subunits in the protein and one or two (G/U)AG repeats in the RNA target to form a binding initiation complex. This complex tethers the RNA to TRAP, thereby reducing its degrees of freedom, as well as partially aligns the remaining triplet repeats with the potential binding sites on the protein. Hence following formation of the initiation complex, the remaining triplet repeats in the RNA bind to TRAP cooperatively, possibly because of an increased local concentration of triplet repeats near the RNA-binding sites on the protein. We have shown that formation of the initiation complex requires interactions between one or two WT subunits and one or two fully functional (G/U)AG repeats containing all the functional groups involved in the complex (15, 24). In contrast, our studies showed that after the initiation complex has formed, the remaining repeats in the RNA can interact with TRAP and contribute to the stability of the complex, even if they lack one of the functional groups that forms a critical hydrogen bond to the protein (24). Similar results were obtained with TRAP hetero-11-mers composed of mixtures of subunits from WT TRAP and a mutant protein lacking one of the amino acid side chains that interacts with the RNA.
In this work we further studied the role of tryptophan binding in the
formation of the TRAP-RNA complex. The low degree of cooperativity
(n = 1.5-2.0 for 11 binding sites) of tryptophan binding to TRAP suggests that WT TRAP may bind fewer than 11 tryptophans under subsaturating conditions. Here we show that binding
of as few as one or two tryptophans dramatically activates RNA binding to TRAP (Kd of 6-12 nM for
(GAGAU)11), as compared with the situation in which there
is no tryptophan bound (Kd
5 µM). In view of our model presented above, these results
suggest that tryptophan binding is required for initiation of RNA
binding but is less essential for subsequent binding steps. Moreover, our results suggest that tryptophan binding induces a conformational change in TRAP in the vicinity of the RNA-binding site on the liganded
subunit(s) (Fig. 4). Together, our findings suggest that tryptophan
binding activates TRAP by inducing a conformational change in an
RNA-binding site, which is essential for initiation of RNA binding,
after which, the tethered RNA can also interact, although
with reduced affinity, with the remaining binding sites on the protein,
even if they have not been activated by bound tryptophan. Thus, these
results also suggest that the RNA-binding sites on TRAP have weak
affinity for (G/U)AG containing RNA even in the absence of tryptophan
and that tryptophan binding serves to increase the affinity enough to
allow formation of the initiation complex. In the crystal structure,
RNA binds to tryptophan-activated TRAP by wrapping around the outside
of the protein ring with each GAG repeat interacting with residues on
two adjacent protein subunits (14). From one subunit, Lys37
interacts with the first G and the second A, whereas Glu36
hydrogen bonds with the third G in the RNA. From the adjacent subunit
Phe32, Lys56, and Arg58 form
hydrogen bonds with the third G (14). The results from a recent NMR
study suggest that tryptophan binding to TRAP reduces the
conformational dynamics of the protein in the region of the tryptophan-binding site as well as in the area where RNA binds, suggesting a mechanism for tryptophan activation of RNA
binding.5
Our studies of hetero-11-mers composed of WT and T25A subunits that mimic partially saturated TRAP 11-mers show that the affinity of TRAP for RNA depends on both the number of tryptophan molecules bound to the protein as well as the number of triplet repeats in the RNA (Table II). WT TRAP binds weakly to RNAs with fewer than five GAG repeats with 14-60-fold lower affinity than for the RNA with 11 GAG repeats (Table II). The influence of the number of repeats on the affinity for TRAP is even greater for UAG repeats (24). Moreover, proteins with subsaturating numbers of bound tryptophan molecules show an even greater influence of the repeats on the stability of the complex (Table II). Hence this feature may be an important property of TRAP to prevent it from interacting with cellular RNAs that contain a few (G/U)AG but are not bona fide sites for regulation.
In B. subtilis, TRAP-mediated regulation involves at least four different RNA targets (26). These contain between 9 and 11 triplet repeats, and in some of these there is rather suboptimal spacing between the repeats (13). Moreover, transcription attenuation control of the trp operon probably requires that TRAP initially recognize and bind to the trp leader RNA before all 11 triplet repeats are synthesized (26). Regulation of expression of each of these genes or operons in response to the tryptophan level depends, in part, on the affinity of TRAP for each site as well as the abundance of each site. Hence they may be regulated differently in response to variations in tryptophan concentration. Consistent with this hypothesis, Yakhnin et al. (27) recently showed that regulation of translation of trpE requires a higher concentration of tryptophan in the growth medium than is required for transcription attenuation control of the trp operon. In addition to affecting the affinity of TRAP for its various RNA targets, the number of tryptophan molecules bound to TRAP may affect the kinetics of the interaction between TRAP and RNA. For example, the dissociation rate of the TRAP-RNA complex is dependent on the concentration of tryptophan (28). This rate is important in vivo because it affects the number of molecules of free TRAP available for binding to its target mRNAs.
Another regulatory protein, AT (anti-TRAP), has
been shown to bind the TRAP-tryptophan complex and prevent RNA binding
(29, 30). Expression of AT is induced by uncharged tRNATrp
(9). The availability of several regulatory mechanisms that can
influence expression of genes involved in tryptophan biosynthesis in
B. subtilis allows this organism to fine-tune tryptophan
synthesis in response to changes in the intracellular level of free and tRNA-charged tryptophan.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Sathyamangalam V. Balsubramanian for assistance with instruments. We thank Jim Stamos, Alan Siegel, and Alfred Antson for preparation of figures and Gerald Koudelka and Charles Yanofsky for critical reading of the manuscript. We also thank the Pharmaceutical Sciences Instrumentation Facility at SUNY for CD data collection.
| |
FOOTNOTES |
|---|
* This work was supported by Grants GM62750 from the National Institutes of Health and MCB 9982652 from the National Science Foundation (to P. G.) and funds from the Mark Diamond Research Fund of State University of New York at Buffalo (to P. T. X. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: Dept. of Chemistry, University of California,
Berkeley, CA 94720.
§ To whom correspondence should be addressed. Tel.: 716-645-2887; Fax: 716-645-2975; E-mail: Gollnick@acsu.buffalo.edu.
Published, JBC Papers in Press, July 19, 2002, DOI 10.1074/jbc.M205910200
2 P. Li, C. Baumann, and P. Gollnick, unpublished observations.
3 P. Li and P. Gollnick, unpublished observations.
4 D. Scott, personal communication.
5 C. McElroy, M. Foster, and P. Gollnick, submitted for publication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: WT, wild type; 5-IAF, 5-iodoacetamidofluorescein.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Henner, D., and Yanofsky, C. (1993) in Bacillus subtilis and Other Gram-positive Bacteria: Biochemistry, Physiology and Molecular Genetics (Sonenshein, A. , Hoch, J. , and Losick, R., eds) , pp. 269-280, American Society of Microbiology, Washington, D.C. |
| 2. |
Kuroda, M.,
Shimotsu, H.,
Henner, D.,
and Yanofsky, C.
(1986)
J. Bacteriol.
167,
792-798 |
| 3. |
Kuroda, M.,
Henner, D.,
and Yanofsky, C.
(1988)
J. Bacteriol.
170,
3080-3087 |
| 4. |
Du, H.,
and Babitzke, P.
(1998)
J. Biol. Chem.
273,
20494-20503 |
| 5. |
Merino, E.,
Babitzke, P.,
and Yanofsky, C.
(1995)
J. Bacteriol.
177,
6362-6370 |
| 6. |
Du, H.,
Tarpey, R.,
and Babitzke, P.
(1997)
J. Bacteriol.
179,
2582-2586 |
| 7. |
Yang, M.,
Saizieu, A.,
Loon, A. P. G. M.,
and Gollnick, P.
(1995)
J. Bacteriol.
177,
4272-4278 |
| 8. |
Sarsero, J.,
Merino, E.,
and Yanofsky, C.
(2000)
J. Bacteriol.
182,
2329-2331 |
| 9. |
Sarsero, J.,
Merino, E.,
and Yanofsky, C.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2656-26661 |
| 10. | Antson, A. A., Otridge, J., Brzozowski, A. M., Dodson, E. J., Dodson, G. G., Wilson, K. S., Smith, T. M., Yang, M., Kurecki, T., and Gollnick, P. (1995) Nature 374, 693-700[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Chen, X., Antson, A. A., Yang, M., Li, P., Baumann, C., Dodson, E. J., Dodson, G. G., and Gollnick, P. (1999) J. Mol. Biol. 289, 1003-1016[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Babitzke, P.,
Bear, D.,
and Yanofsky, C.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
7916-7920 |
| 13. |
Babitzke, P.,
Yealy, J.,
and Campanelli, D.
(1996)
J. Bacteriol.
178,
5159-5163 |
| 14. | Antson, A. A., Dodson, E. J., Dodson, G. G., Greaves, R. B., Chen, X., and Gollnick, P. (1999) Nature 401, 235-242[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Li, P.,
Scott, D.,
and Gollnick, P.
(2002)
J. Biol. Chem.
277,
11838-11844 |
| 16. |
Babitzke, P.,
and Yanofsky, C.
(1995)
J. Biol. Chem.
270,
12452-12456 |
| 17. |
Yakhnin, A.,
Trimble, J.,
Chiaro, C.,
and Babitzke, P.
(2000)
J. Biol. Chem.
275,
4519-4524 |
| 18. | Yang, M., Chen, X., Militello, K., Hoffman, R., Fernandez, B., Baumann, C., and Gollnick, P. (1997) J. Mol. Biol. 270, 696-710[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Otridge, J.,
and Gollnick, P.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
128-132 |
| 20. |
Baumann, C.,
Xirasagar, S.,
and Gollnick, P.
(1997)
J. Biol. Chem.
272,
19863-19869 |
| 21. | Segel, I. H. (1975) in Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-state Enzyme Systems (Segel, I. H., ed) , pp. 360-361, John Wiley & Sons Inc., New York |
| 22. | Cantor, C., and Schimmel, P. (1980) Biophysical Chemistry , Vol. III , p. 864, W. H. Freeman and Company |
| 23. |
Xirasagar, S.,
Elliott, M.,
Bartolini, W.,
Gollnick, P.,
and Gottlieb, P.
(1998)
J. Biol. Chem.
273,
27146-27153 |
| 24. | Elliott, M., Gottlieb, P., and Gollnick, P. (2001) RNA 7, 85-93[Abstract] |
| 25. |
Gollnick, P.,
Ishino, S.,
Kuroda, M.,
Henner, D.,
and Yanofsky, C.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
8726-8730 |
| 26. |
Babitzke, P.,
and Gollnick, P.
(2001)
J. Bacteriol.
183,
5795-5802 |
| 27. |
Yakhnin, H.,
Babiarz, J.,
Yakhnin, A.,
and Babitzke, P.
(2001)
J. Bacteriol.
183,
5918-5926 |
| 28. |
Baumann, C.,
Otridge, J.,
and Gollnick, P.
(1996)
J. Biol. Chem.
271,
12269-12274 |
| 29. |
Valbuzzi, A.,
and Yanofsky, C.
(2001)
Science
293,
2057-2059 |
| 30. |
Valbuzzi, A.,
Gollnick, P.,
Babitzke, P.,
and Yanofsky, C.
(2002)
J. Biol. Chem.
277,
10608-10613 |
This article has been cited by other articles:
![]() |
V. Payal and P. Gollnick Substitutions of Thr30 provide mechanistic insight into tryptophan-mediated activation of TRAP binding to RNA Nucleic Acids Res., May 31, 2006; 34(10): 2933 - 2942. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. McCabe and P. Gollnick Cellular Levels of trp RNA-Binding Attenuation Protein in Bacillus subtilis J. Bacteriol., August 1, 2004; 186(15): 5157 - 5159. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| < |